🇺🇸 FDA
Patent

US 8449911

Drug composition having active ingredient adhered at high concentration to spherical core

granted A61KA61K31/4439A61K9/1652

Quick answer

US patent 8449911 (Drug composition having active ingredient adhered at high concentration to spherical core) held by Takeda Pharmaceutical Company Limited expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4439, A61K9/1652, A61K9/5073, A61P